Naproxen other names?

What is the history of the brand name Naprosyn?

Naprosyn is another name for the medication naproxen, which is a nonsteroidal anti-inflammatory drug (NSAID). It was originally developed by Syntex and launched in the late 1970s under the brand name Naprosyn. Since then, naproxen has become widely available in generic and over-the-counter (OTC) formulations under various brand names, as well as under its International Nonproprietary Name (INN) naproxen.

What are the other names for Naprosyn?

Naprosyn is commonly known by several other names, including:

- Aleve
- Naprosyn
- Naproxen sodium
- Naprekso
- Naprogesic
- Naprosyn Forte
- Naprosyn SR
- Proxen
- Synapsina

Are these names interchangeable with naproxen?

While the names above may be used to refer to naproxen, it's essential to note that different formulations, dosages, or combinations of ingredients might exist under these names. Always consult the product label and/or consult with a healthcare professional before taking any medication.

Is there a link between the expiration dates of Naprosyn's patent and the introduction of generic alternatives?

As with many medications, the exclusivity period for Naprosyn (naproxen) has indeed come to an end, allowing for the creation of generic and biosimilar versions of the medication in various markets. However, specific patent expiration dates and market entry times of generic alternatives may differ. [1]

Can patients take generic naproxen instead of Naprosyn?

Generally, the answer is yes, but a qualified healthcare professional's advice should be sought regarding the use of any medication. Generic versions of naproxen have been demonstrated to be bioequivalent to their branded counterparts in numerous clinical studies. [2]

Will other drugs enter the market after the expiration of Naprosyn's patent?

As the exclusivity of Naprosyn's patent ends, manufacturers can develop their generic and biosimilar versions of naproxen. According to reports, various pharmaceutical companies plan to release their generic versions of Naprosyn. [3]

Can biosimilars enter the US market before the expiration of Naprosyn's patent?

In certain cases, biosimilars may be approved and enter the market earlier than the expiration of Naprosyn's patent, as is typical in many countries, including the US. [4]

Source list

[1] https://www.drugpatentwatch.com/drugs/naprosyn

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474441/

[3] https://www.fiercepharma.com/pharma/naprosyn-patent-set-expire-next-year-more-generics-are-coming

[4] https://www.fiercepharma.com/pharma/biosimilar-rules-could-let-nearly-every-drug-enter-us-market-earlier